MobilMed, founded in 2015 and headquartered in Turkey, specializes in the fusion of hardware, health care, and medical devices sectors. The company's slogan, "Subscription-based service for customized heart health tracking," encapsulates its core offering: a subscription model providing continuous and personalized cardiac health monitoring through advanced wearable medical technologies.
Leveraging machine learning platforms, MobilMed distinguishes itself by offering customized health insights and proactive health management for its users. The focus on personalization and continuous monitoring taps into a growing demand for preventive care, making it an attractive prospect within the healthcare industry.
The company secured a $50.00K seed investment as of 01 March 2019, indicating an initial belief in its potential. However, with few details available on follow-up investments or named investors, potential investors should assess MobilMed's traction, market penetration, and future funding strategies to gauge its readiness for scale and long-term growth prospects.